汉字News

← 汉字News
Chinese News for Learners
commerce
shāng yè
商业
·HSK 4

Eli Lilly (pharmaceutical company)
Lǐlái
礼来
weight loss / weight reduction
jiǎnzhòng
减重
drugs / medications
yàowù
药物
sales revenue / sales figure
xiāoshòu é
销售额
to set (a record)
chuàng
all-time high / record high
lìshǐ xīngāo
历史新高
quarterly
jìdù
季度
revenue
yíngshōu
营收
year-over-year
tóngbǐ
同比
to surge / to skyrocket
biāoshēng
飙升
56 percent
56%
56%

Eli Lilly (pharmaceutical company)
Lǐlái
礼来
under the umbrella of / belonging to
qíxià
旗下
diabetes
tángniàobìng
糖尿病
drug / medication
yàowù
药物
Mounjaro (diabetes and weight loss drug by Eli Lilly)
Mounjaro
Mounjaro
quarterly
jìdù
季度
sales revenue
xiāoshòu é
销售额
to grow / to increase
zēngzhǎng
增长
125 percent
125%
125%
to / reaching
zhì
$8.7 billion
87 yì měiyuán
87亿美元
weight loss drug
jiǎnféi yào
减肥药
Zepbound (obesity treatment drug by Eli Lilly)
Zepbound
Zepbound
to grow
zēngzhǎng
增长
79 percent
79%
79%
to / reaching
zhì
$4.1 billion
41 yì měiyuán
41亿美元

May 1, 2026 at 7:00 AM

United States
Měiguó
美国
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Eli Lilly (pharmaceutical company)
Lǐlái
礼来
on (a date)
April 30
4 yuè 30 rì
4月30日
to announce / to release
gōngbù
公布
first quarter
dìyī jìdù
第一季度
financial report / earnings report
cáibào
财报
revenue
yíngshōu
营收
year-over-year
tóngbǐ
同比
to grow / to increase
zēngzhǎng
增长
56 percent
56%
56%
to / reaching
zhì
$19.8 billion
198 yì měiyuán
198亿美元
diabetes
tángniàobìng
糖尿病
treatment / therapeutic
zhìliáo
治疗
drug / medication
yàowù
药物
Mounjaro (diabetes and weight loss drug)
Mounjaro
Mounjaro
sales revenue
xiāoshòu é
销售额
year-over-year
tóngbǐ
同比
to surge / to jump sharply
dàzhǎng
大涨
125 percent
125%
125%
to reach / to achieve
dádào
达到
$8.7 billion
87 yì měiyuán
87亿美元
weight loss medication
jiǎnféi yàowù
减肥药物
Zepbound (obesity treatment drug)
Zepbound
Zepbound
in / at
zài
the United States
Měiguó
美国
(structural particle)
de
sales revenue
xiāoshòu é
销售额
year-over-year
tóngbǐ
同比
to grow
zēngzhǎng
增长
79 percent
79%
79%
to / reaching
zhì
$4.1 billion
41 yì měiyuán
41亿美元
market
shìchǎng
市场
demand
xūqiú
需求
to continue / ongoing
chíxù
持续
strong / robust
qiángjìng
强劲
driven by / buoyed by
shòu
results / performance
yèjì
业绩
to drive / to boost
dàidòng
带动
Eli Lilly
Lǐlái
礼来
stock price / share price
gǔjià
股价
on the same day
dāngrì
当日
to rise / to go up
shàngzhǎng
上涨
nearly / close to
jìn
7 percent
7%
7%
market
shìchǎng
市场
sentiment / mood
qíngxù
情绪
noticeably / clearly
míngxiǎn
明显
to improve / to turn positive
hǎozhuǎn
好转
Eli Lilly
Lǐlái
礼来
thereupon / immediately
suíjí
随即
will / to
jiāng
year 2026
2026 nián
2026年
full-year
quánnián
全年
revenue
yíngshōu
营收
guidance / forecast
yùqī
预期
to raise / to revise upward
shàngtiáo
上调
to / in the range of
zhì
$82 billion
820 yì
820亿
to
zhì
$85 billion
850 yì měiyuán
850亿美元
in addition / furthermore
cǐwài
此外
the United States
Měiguó
美国
the FDA / Food and Drug Administration
Shípǐn hé Yàowù Guǎnlǐjú
食品和药物管理局
to approve
pīzhǔn
批准
(completion marker)
le
Eli Lilly
Lǐlái
礼来
under the umbrella of
qíxià
旗下
the first / the inaugural
shǒu kuǎn
首款
oral / taken by mouth
kǒufú
口服
weight loss drug
jiǎnféi yào
减肥药
Foundayo (oral weight loss pill by Eli Lilly)
Foundayo
Foundayo
further / additionally
jìnyībù
进一步
to expand
kuòzhǎn
扩展
(completion marker)
le
the company
gōngsī
公司
weight loss / weight management
jiǎnzhòng
减重
product line
chǎnpǐn xiàn
产品线

New Words

zhìyào jùtóu
制药巨头
pharmaceutical giant
Lǐlái
礼来
Eli Lilly
cáibào
财报
financial report
tángniàobìng
糖尿病
diabetes
zhìliáo
治疗
treatment
Mounjaro
Mounjaro
Mounjaro (diabetes drug)
jiǎnféi yào
减肥药
weight loss medication
gǔjià
股价
stock price
yùqī
预期
forecast/guidance
Shípǐn hé Yàowù Guǎnlǐjú
食品和药物管理局
FDA

News in English

Business

Eli Lilly Weight Loss Drug Sales Hit Record as Q1 Revenue Surges 56 Percent

Eli Lilly diabetes drug Mounjaro quarterly sales grew 125 percent to $8.7 billion, and weight loss drug Zepbound grew 79 percent to $4.1 billion. The company raised its full-year guidance and won FDA approval for its first oral weight loss pill.

US pharmaceutical giant Eli Lilly announced its first quarter financial results on April 30, with revenue growing 56% year-over-year to $19.8 billion. The diabetes treatment drug Mounjaro sales surged 125% year-over-year, reaching $8.7 billion. The weight loss medication Zepbound sales in the US grew 79% year-over-year to $4.1 billion, with robust continuing market demand.

Driven by the strong earnings, Eli Lilly's stock price rose nearly 7% on the day, with market sentiment showing marked improvement. Eli Lilly subsequently raised its full-year 2026 revenue guidance to $82-85 billion.

Additionally, the US Food and Drug Administration approved Eli Lilly's first oral weight loss pill, Foundayo, further expanding the company's weight management product line.

More in Business

data
shùjù
数据
analysis
fēnxī
分析
company
gōngsī
公司
EXL (data analytics company)
EXL
EXL
to announce
xuānbù
宣布
to acquire
shōugòu
收购
artificial intelligence
rén gōng zhì néng
人工智能
training
xùnliàn
训练
company
gōngsī
公司
iMerit (AI training company)
iMerit
iMerit

Data Analytics Firm EXL to Acquire AI Training Company iMerit for Up to $310 Million

MSCI (financial data company)
Míngshèng
明晟
for / at (a price)
$120 million
1.2 yì měiyuán
1.2亿美元
to acquire / acquisition
shōugòu
收购
climate
qìhòu
气候
risk
fēngxiǎn
风险
data
shùjù
数据
company
gōngsī
公司
First Street (climate data company)
First Street
First Street

MSCI Acquires Climate Risk Data Firm First Street for $120 Million

Samsung (company)
Sānxīng
三星
to announce
xuānbù
宣布
within ten years
shí nián nèi
十年内
in / at
zài
South Korea
Hánguó
韩国
to invest
tóuzī
投资
$648 billion
6480 yì měiyuán
6480亿美元

Samsung Pledges $648 Billion Investment in South Korea Over Next Decade

fourth
dì sì jiè
第四届
China
zhōngguó
中国
international
guójì
国际
supply chain
gōngyìng liàn
供应链
expo
bólǎn huì
博览会
in
zài
Beijing
běijīng
北京
opens
kāimù
开幕

Fourth China International Supply Chain Expo Opens in Beijing